2020 ISPE Asia Pacific Pharma Manufacturing Virtual Conference & Executive Forum
Bracing for Impact:
Best Practices for Maintaining Pharmaceutical Supply Chain Continuity in a Complex and Dynamic Environment
The 2020 ISPE Asia Pacific Pharmaceutical Manufacturing Virtual Conference and Executive Forum provides you with access to regulatory intelligence on emerging supply chain, quality, and compliance challenges in light of COVID-19. Participate in actionable, interactive discussions featuring case studies and dedicated Q&A time with experts representing global health authorities, including FDA and MHRA.
Benefit from unparalleled real-time engagement with regulatory leaders as they share companies' best practices to assess critical manufacturing processes and lessons learned to improve and sustain a reliable supply of quality medicine. Plus, stay knowledgeable throughout the year with on demand access to ALL session recordings and presentations for 12 months.
The Executive Forum, led by global regulators and industry leaders, is an interactive discussion forum for pharmaceutical executives. The focus of this year’s Forum will be on post-COVID-19 assessment of the impact on the pharmaceutical supply chain and lessons learned for the pharmaceutical manufacturing industry.
Collaboratively explore opportunities facing pharmaceutical leaders and regulators to develop strategies for enhanced supply chain visibility and control.
Executive Forum Topics Include
Impact of COVID-19 on the pharmaceutical supply chain
Sustainable supply chain visibility & control strategies
Post-COVID-19 assessment/lessons learned
Redundancy in facilities and operations
Supply chain security in times of crisis
Global regulatory agency interaction
Alternate inspection approaches
*The Forum is included with Conference Registration
Although travel continues to be reduced or restricted across the world, there is an upside: The 2020 ISPE Asia Pacific Pharmaceutical Manufacturing Virtual Conference & Executive Forum has now pivoted into a fully virtual conference and virtual executive...
Attendees will be able to:
Assess the impact of COVID-19 on their company’s supply chain visibility and control
Apply lessons learned from companies impacted by the pandemic in their own organization
Become current on industry trends in quality & compliance as supply chains evolve
Work with CMOs to mitigate supply chain disruptions
Understand quality and regulatory requirements and expectations
Understand the necessary elements and compliance for quality sustainability
Who Should Attend?
Executive Level Leaders in Pharmaceutical and Biopharmaceutical Supply Chain
Manufacturing & Operations professionals Quality Assurance professionalsQuality Control professionalsRegulatory Body personnelRegulatory Affairs expertsPharma Senior Level Managers